Semi-Annual Consolidated Balance Sheet

Oncolys BioPharma Inc. - Filing #7339370

Concept As at
2024-03-31
As at
2023-12-31
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,478,109,000 JPY
1,532,844,000 JPY
Other
JPY
9,000 JPY
Current assets
2,056,553,000 JPY
1,955,883,000 JPY
Non-current assets
Property, plant and equipment
JPY
JPY
Property, plant and equipment
Investments and other assets
87,189,000 JPY
84,714,000 JPY
Investments and other assets
Other
4,000 JPY
4,000 JPY
Non-current assets
87,189,000 JPY
84,714,000 JPY
Assets
2,143,742,000 JPY
2,040,598,000 JPY
Liabilities
Current liabilities
Short-term borrowings
124,990,000 JPY
127,776,000 JPY
Lease liabilities
7,070,000 JPY
7,565,000 JPY
Income taxes payable
8,111,000 JPY
18,844,000 JPY
Current liabilities
232,486,000 JPY
378,531,000 JPY
Non-current liabilities
Long-term borrowings
138,884,000 JPY
161,100,000 JPY
Lease liabilities
17,350,000 JPY
18,729,000 JPY
Non-current liabilities
163,097,000 JPY
187,969,000 JPY
Liabilities
395,583,000 JPY
566,500,000 JPY
Net assets
Shareholders' equity
Share capital
3,945,814,000 JPY
3,623,165,000 JPY
Capital surplus
1,532,239,000 JPY
1,209,590,000 JPY
Retained earnings
-3,737,433,000 JPY
-3,373,199,000 JPY
Treasury shares
-142,000 JPY
-142,000 JPY
Shareholders' equity
1,740,478,000 JPY
1,459,413,000 JPY
Share acquisition rights
7,680,000 JPY
14,683,000 JPY
Net assets
1,748,158,000 JPY
1,474,097,000 JPY
Liabilities and net assets
2,143,742,000 JPY
2,040,598,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.